| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2718628 | The American Journal of Medicine | 2013 | 9 Pages |
Abstract
Among subjects with rheumatoid arthritis, TNF-α blocking agents may be associated with a reduced risk of cardiovascular events compared with an nbDMARD. Randomized controlled clinical trials should be considered to test this hypothesis.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Daniel H. MD, MPH, Jeffrey R. MD, MSc, Kenneth G. MD, MSc, Joyce MSc, Lang PhD, Leslie R. MD, MPH, Lisa J. PhD, David J. MD, MPH, Mary K. BA, Bindee MD, MSc, Liyan MD, MSc, Marie R. MD, MPH, James D. MD, MSCE, Jeremy A. ScD,